Rectal insulin does well in trials
This article was originally published in Scrip
Executive Summary
The Israeli biotech company Oramed has just announced that Phase I trials in South Africa of its rectal insulin formulation, ORMD-0802, have shown that the hormone is rapidly absorbed and is well tolerated.